Comparative in Vitro Activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2401-2404

  Goldstein, Ellie J C ^a,b   Citron, Diane M ^a   Tyrrell, Kerin L ^a   Merriam, C Vreni ^a  

^a R M ALDEN RESEARCH LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GSK 2251052; IMIPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

AGAR DILUTION; ANAEROBIC BACTERIUM; ARTICLE; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; BIFIDOBACTERIUM; BILOPHILA WADSWORTHIA; BROTH DILUTION; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; COMPARATIVE STUDY; EGGERTHELLA LENTA; EUBACTERIUM; FUSOBACTERIUM; LACTOBACILLUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL;

ANAEROBIOSIS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTEROIDES; BACTEROIDES FRAGILIS; BORON COMPOUNDS; CLOSTRIDIUM PERFRINGENS; ENZYME INHIBITORS; HUMANS; LEUCINE-TRNA LIGASE; MICROBIAL SENSITIVITY TESTS;

EID: 84876259369     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02580-12     Document Type: Article

References (9)

1. Hernandez V, Akama T, Alley MRK, Baker S, Mao W, Rock F, Zhang YK, Zhang Y, Zhou Y, Crepin T, Cusack S, Palencia A, Nieman J, Anugula M, Baek M, Diaper C, Ha C, Kermane M, Lu X, Mohammad R, Savariraj K, Sharma R, Singh R, Subedi R, Plattner J. 2011. Discovery and mechanism of action of AN3365; a novel boron-containing antibacterial agent in clinical development for Gram-negative infections, abstr F1-1637. Fifty-first Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL, 17 to 20 September 2011.
2. Sutcliffe JA. 2011. Antibiotics in development targeting protein synthesis. Ann. N. Y. Acad. Sci. 124:122-152.
3. Mendez RE, Biedenbach DJ, Alley MRK, Sader HS, Jones RN. 2011. Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against Enterobacteriaceae, abstr F1- 1638. Fifty-first Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL, 17 to 20 September 2011.
4. Bouchillon SK, Hoban DJ, Hackel MA, Butler DL, Memarsh P, Alley MRK. 2010. In vitro activities of AN3365: a novel boron containing protein synthesis inhibitor, and other antimicrobial agents against anaerobes and Neisseria gonorrhea, abstr F1-1640. Fiftieth Intersci. Conf. Antimicrob. Agents Chemother., Boston, MA, 12 to 15 September 2010.
5. Goldstein EJC, Citron DM, Tyrrell KL, Merriam VC. 2011. Fifty-first Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL, 17 to 20 September 2011, abstr E-111.
6. Jousimies-Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM. 2002. Wadsworth-KTL anaerobic bacteriology manual. Star Publishing, Belmont, CA.
7. Warren YA, Tyrrell KL, Citron DM, Goldstein EJC. 2006. Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. isolated from human clinical specimens. J. Clin. Microbiol. 44:2416-2422.
8. Clinical and Laboratory Standards Institute. 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteri approved standard, 7th ed. CLSI document M11-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Bouchillon SK, Hackel M, Hoban DJ, Howser SP, Scangarella-Oman NE. 2011. GSK2251052, a novel boron-containing protein synthesis inhibitor, with comparative in vitro activity against Pseudomonas aeruginosa from a global population, abstr E-129. Fifty-first Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL, 17 to 20 September 2011.